The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
Open accessAbstract
A robust personalized ctDNA test, TARDIS, achieves high accuracy for residual disease after completion of neoadjuvant therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primer3—new capabilities and interfaces
Untergasser, A., Cutcutache, I., Koressaar, T., Ye, J., Faircloth, B. C., Remm, M., & Rozen, S. G. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks596 · Cited by 9,461
Van der Auwera, G. A., Carneiro, M. O., Hartl, C., Poplin, R., del Angel, G., Levy‐Moonshine, A., Jordan, T., Shakir, K., Roazen, D., Thibault, J., et al. (2013) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1110s43 · Cited by 6,687
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E. S., & Getz, G. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,981
Aligning sequence reads, clone sequences and assembly con*gs with BWA-MEM
Li, H. (2014) · arXiv (Cornell University) · doi:10.6084/m9.figshare.963153.v1 · Cited by 4,932
Haplotype-based variant detection from short-read sequencing
Garrison, E., & Marth, G. (2012) · arXiv · doi:10.48550/arxiv.1207.3907 · Cited by 3,700
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
Sparano, J. A., Gray, R. J., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., Olson, J. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804710 · Cited by 2,397
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213261 · Cited by 2,207
Self-citationSmith, T., Heger, A., & Sudbery, I. (2017) · Genome Research · doi:10.1101/gr.209601.116 · Cited by 2,143
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
The TRACERx consortium, Abbosh, C., The PEACE consortium, Birkbak, N. J., Wilson, G. A., Jamal-Hanjani, M., Constantin, T., Salari, R., Le Quesne, J., Moore, D. A., et al. (2017) · Nature · doi:10.1038/nature22364 · Cited by 1,874
Pereira, B., Chin, S.-F., Rueda, O. M., Vollan, H.-K. M., Provenzano, E., Bardwell, H. A., Pugh, M., Jones, L., Russell, R., Sammut, S.-J., et al. (2016) · Nature Communications · doi:10.1038/ncomms11479 · Cited by 1,717
Self-citationStrelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs
Saunders, C. T., Wong, W. S. W., Swamy, S., Becq, J., Murray, L. J., & Cheetham, R. K. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts271 · Cited by 1,635
Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H.-L., Christie, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6219 · Cited by 1,492 · cited 1×
“Earlier studies investigating ctDNA quantification for longitudinal treatment monitoring have targeted single recurrent or patient-specific mutations using digital PCR or digital sequencing (8, 20).”
MethodForshew, T., Murtaza, M., Parkinson, C., Gale, D., Tsui, D. W. Y., Kaper, F., Dawson, S.-J., Piskorz, A. M., Jimenez-Linan, M., Bentley, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003726 · Cited by 1,297
Self-citationAdaptive seeds tame genomic sequence comparison
Kiełbasa, S. M., Wan, R., Sato, K., Horton, P., & Frith, M. C. (2011) · Genome Research · doi:10.1101/gr.113985.110 · Cited by 1,281
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Garcia-Murillas, I., Schiavon, G., Weigelt, B., Ng, C., Hrebien, S., Cutts, R. J., Cheang, M., Osin, P., Nerurkar, A., Kozarewa, I., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0021 · Cited by 1,150
Detection and quantification of rare mutations with massively parallel sequencing
Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105422108 · Cited by 1,144
Direct detection of early-stage cancers using circulating tumor DNA
Phallen, J., Sausen, M., Adleff, V., Leal, A., Hruban, C., White, J., Anagnostou, V., Fiksel, J., Cristiano, S., Papp, E., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan2415 · Cited by 1,119
Integrated digital error suppression for improved detection of circulating tumor DNA
Newman, A. M., Lovejoy, A. F., Klass, D. M., Kurtz, D. M., Chabon, J. J., Scherer, F., Stehr, H., Liu, C. L., Bratman, S. V., Say, C., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3520 · Cited by 1,099
Chaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A. M., Stehr, H., Azad, T. D., Khodadoust, M. S., Esfahani, M. S., Liu, C. L., Zhou, L., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0716 · Cited by 1,072
PyClone: statistical inference of clonal population structure in cancer
Roth, A., Khattra, J., Yap, D., Wan, A., Laks, E., Biele, J., Ha, G., Aparicio, S., Bouchard-Côté, A., & Shah, S. P. (2014) · Nature Methods · doi:10.1038/nmeth.2883 · Cited by 999
Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data
Favero, F., Joshi, T., Marquard, A. M., Birkbak, N. J., Krzystanek, M., Li, Q., Szallasi, Z., & Eklund, A. C. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu479 · Cited by 836
Symmans, W. F., Wei, C., Gould, R., Yu, X., Zhang, Y., Liu, M., Walls, A., Bousamra, A., Ramineni, M., Sinn, B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.1010 · Cited by 711
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
McGranahan, N., Favero, F., de Bruin, E. C., Birkbak, N. J., Szallasi, Z., & Swanton, C. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1408 · Cited by 685
Murtaza, M., Dawson, S.-J., Pogrebniak, K., Rueda, O. M., Provenzano, E., Grant, J., Chin, S.-F., Tsui, D. W. Y., Marass, F., Gale, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms9760 · Cited by 483
Self-citationTie, J., Cohen, J. D., Wang, Y., Li, L., Christie, M., Simons, K., Elsaleh, H., Kosmider, S., Wong, R., Yip, D., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-315852 · Cited by 381
Anagnostou, V., Forde, P. M., White, J. R., Niknafs, N., Hruban, C., Naidoo, J., Marrone, K., Sivakumar, I. K. A., Bruhm, D. C., Rosner, S., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1127 · Cited by 318
Chagpar, A. B., Middleton, L. P., Sahin, A. A., Dempsey, P., Buzdar, A. U., Mirza, A. N., Ames, F. C., Babiera, G. V., Feig, B. W., Hunt, K. K., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000197714.14318.6f · Cited by 245
Stover, D. G., Parsons, H. A., Ha, G., Freeman, S. S., Barry, W. T., Guo, H., Choudhury, A. D., Gydush, G., Reed, S. C., Rhoades, J., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.0033 · Cited by 231
Cercek, A., Goodman, K. A., Hajj, C., Weisberger, E., Segal, N. H., Reidy-Lagunes, D. L., Stadler, Z. K., Wu, A. J., Weiser, M. R., Paty, P. B., et al. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0056 · Cited by 224
Riva, F., Bidard, F.-C., Houy, A., Saliou, A., Madic, J., Rampanou, A., Hego, C., Milder, M., Cottu, P., Sablin, M.-P., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.262337 · Cited by 213
Evaluation of pre-analytical factors affecting plasma DNA analysis
Markus, H., Contente‐Cuomo, T., Farooq, M., Liang, W. S., Borad, M. J., Sivakumar, S., Gollins, S., Tran, N. L., Dhruv, H., Berens, M. E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25810-0 · Cited by 171
Self-citationNarayan, A., Carriero, N. J., Gettinger, S. N., Kluytenaar, J., Kozak, K. R., Yock, T. I., Muscato, N. E., Ugarelli, P., Decker, R. H., & Patel, A. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4037 · Cited by 165
Yuan, Y., Chen, X., Liu, S., & Shen, K. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.09.3908 · Cited by 150
Ståhlberg, A., Krzyzanowski, P. M., Jackson, J., Egyud, M., Stein, L. D., & Godfrey, T. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw224 · Cited by 145
Rothé, F., Silva, M. J., Venet, D., Campbell, C., Bradburry, I., Rouas, G., de Azambuja, E., Maetens, M., Fumagalli, D., Rodrik-Outmezguine, V. S., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2521 · Cited by 138
Christoforides, A., Carpten, J. D., Weiss, G. J., Demeure, M. J., Hoff, D. D. V., & Craig, D. W. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-302 · Cited by 92
Cortazar, P., Zhang, L., Untch, M., Mehta, K. M., Costantino, J. P., Wolmark, N., Bonnefoi, H. R., Cameron, D., Gianni, L., Valagussa, P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.sabcs12-p1-14-20 · Cited by 78
Abstract 1: Oncogenic extracellular domain mutations of ERBB2 in cancer
Greulich, H. E., Kaplan, B., Mertins, P., Chen, T.-H., Tanaka, K., Yun, C., Imielinski, M. B., Banerji, S., Lawrence, M. S., Walker, S. R., et al. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-1 · Cited by 62
A hybridization-based approach for quantitative and low-bias single-stranded DNA ligation
Kwok, C. K., Ding, Y., Sherlock, M. E., Assmann, S. M., & Bevilacqua, P. C. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.01.008 · Cited by 43
Butler, T. M., Boniface, C. T., Johnson-Camacho, K., Tabatabaei, S., Melendez, D., Kelley, T., Gray, J. W., Corless, C. L., & Spellman, P. T. (2019) · Molecular Case Studies · doi:10.1101/mcs.a003772 · Cited by 34
Cited by
Liquid biopsy enters the clinic — implementation issues and future challenges
Ignatiadis, M., Sledge, G. W., & Jeffrey, S. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00457-x · Cited by 1,191
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival
Magbanua, M. J. M., Swigart, L. B., Wu, H.-T., Hirst, G. L., Yau, C., Wolf, D. M., Tin, A., Salari, R., Shchegrova, S., Pawar, H., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2020.11.007 · Cited by 462
Parikh, A. R., Van Seventer, E. E., Siravegna, G., Hartwig, A. V., Jaimovich, A., He, Y., Kanter, K., Fish, M. G., Fosbenner, K. D., Miao, B., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0410 · Cited by 380
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
Kilgour, E., Rothwell, D. G., Brady, G., & Dive, C. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.012 · Cited by 360
Gale, D., Heider, K., Ruiz-Valdepenas, A., Hackinger, S., Perry, M., Marsico, G., Rundell, V., Wulff, J., Sharma, G., Knock, H., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.02.007 · Cited by 335
Metadata
- Authors
- McDonald, B. R., Contente-Cuomo, T., Sammut, S.-J., Odenheimer-Bergman, A., Ernst, B., Perdigones, N., Chin, S.-F., Farooq, M., Mejia, R., Cronin, P. A., Anderson, K. S., Kosiorek, H. E., Northfelt, D. W., McCullough, A. E., Patel, B. K., Weitzel, J. N., Slavin, T. P., Caldas, C., Pockaj, B. A., & Murtaza, M.
- Venue
- Science Translational Medicine
- Published
- 2019-08-07
- Volume
- 11
- Issue
- 504
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2965583450
- Cited by
- 305
- References
- 42
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.